Assessment of morbidity due to Schistosoma japonicum infection in China
about
Major parasitic diseases of poverty in mainland China: perspectives for better controlParasite Infection, Carcinogenesis and Human MalignancyComprehensive Transcriptome Analysis of Sex-Biased Expressed Genes Reveals Discrete Biological and Physiological Features of Male and Female Schistosoma japonicumPutting the treatment of paediatric schistosomiasis into context.Approaches being used in the national schistosomiasis elimination programme in China: a review.Infectious Diseases of Poverty, the first five yearsShort-Term Efficacy of Laparoscopic Treatment for Colorectal Cancer in Patients with Schistosomiasis JaponicaPlasma D-dimer Can Effectively Predict the Prospective Occurrence of Ascites in Advanced Schistosomiasis Japonica PatientsSerum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor ImatinibGdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine LiverComparison of non-schistosomal rectosigmoid cancer and schistosomal rectosigmoid cancerEvidence That Rhesus Macaques Self-Cure from a Schistosoma japonicum Infection by Disrupting Worm Esophageal Function: A New Route to an Effective Vaccine?Field evaluation of a recombinase polymerase amplification assay for the diagnosis of Schistosoma japonicum infection in Hunan province of China.A next-generation microarray further reveals stage-enriched gene expression pattern in the blood fluke Schistosoma japonicum.A multidisciplinary, integrated approach for the elimination of schistosomiasis: a longitudinal study in a historically hyper-endemic region in the lower reaches of the Yangtze River, China from 2005 to 2014An integrated environmental improvement of marshlands: impact on control and elimination of schistosomiasis in marshland regions along the Yangtze River, China.Interruption of schistosomiasis transmission in mountainous and hilly regions with an integrated strategy: a longitudinal case study in Sichuan, China.New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China.Long-term effectiveness of the integrated schistosomiasis control strategy with emphasis on infectious source control in China: a 10-year evaluation from 2005 to 2014.Abnormal liver function in different patients with Schistosoma japonicum.Schistosomiasis Japonica Control in Domestic Animals: Progress and Experiences in China.The ratio of the seroprevalence to the egg-positive prevalence of Schistosoma japonicum in China: a meta-analysis
P2860
Q26740426-D5D81D78-ACF3-4BD8-BBAC-5564B3FE3EE2Q28067519-CA4E56EE-A619-4982-BDFA-2AC9AF432D72Q28551703-3001A198-4F34-4DF5-9B55-116F85AF0025Q30234902-0C58B0B2-383B-4189-A72C-93AC77F90FABQ30235288-EDC825D7-4C40-49D7-9A46-E4E1F535421BQ30250989-ABBDDB6F-EB44-4913-83C1-739D012CDB3FQ33436738-B0B3182E-8B86-4DAE-A07F-4E1F451072E3Q33745547-722F7690-096F-4C83-9A8A-5AB90E6AC86CQ34705820-622B1B70-E850-47ED-B260-61E5CBB7E9F2Q35758674-85182AD4-7360-4683-9C59-639F3CCA2A64Q35767898-CF6EF52D-8B49-4C75-AF4D-0577EB74837FQ35838678-55F0626A-8CC7-4B07-9862-8C0B3D0C2669Q36286649-125FC350-5708-406D-97EE-62C6847AC26CQ37576422-3AEBCDC2-4C1E-47F8-A3A3-99A853EC0BE1Q37697955-8350418E-0137-40B4-B854-E972A50A04E0Q37715763-EAA51393-0A65-4C1E-9F39-97A9637AC6B7Q37740971-322DB9A4-63E8-47EE-A428-38EF305D5EB8Q38253124-599F0A01-3FDC-4F58-A1DC-55E234657532Q39216056-535878C9-9F66-4E2F-9F28-BF8E2E2AEE4DQ41713927-719BAEEE-A990-4C27-BC0C-0E175566E5CAQ47421629-C281242A-837B-474C-8604-4DF64A2B1B7BQ58778000-C9BC86DD-E7E8-4758-9185-2C336C1F2983
P2860
Assessment of morbidity due to Schistosoma japonicum infection in China
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Assessment of morbidity due to Schistosoma japonicum infection in China
@ast
Assessment of morbidity due to Schistosoma japonicum infection in China
@en
Assessment of morbidity due to Schistosoma japonicum infection in China
@en-gb
Assessment of morbidity due to Schistosoma japonicum infection in China
@nl
type
label
Assessment of morbidity due to Schistosoma japonicum infection in China
@ast
Assessment of morbidity due to Schistosoma japonicum infection in China
@en
Assessment of morbidity due to Schistosoma japonicum infection in China
@en-gb
Assessment of morbidity due to Schistosoma japonicum infection in China
@nl
prefLabel
Assessment of morbidity due to Schistosoma japonicum infection in China
@ast
Assessment of morbidity due to Schistosoma japonicum infection in China
@en
Assessment of morbidity due to Schistosoma japonicum infection in China
@en-gb
Assessment of morbidity due to Schistosoma japonicum infection in China
@nl
P2860
P3181
P356
P1476
Assessment of morbidity due to Schistosoma japonicum infection in China
@en
P2093
Ming-Gang Chen
P2860
P2888
P3181
P356
10.1186/2049-9957-3-6
P407
P5008
P577
2014-01-01T00:00:00Z
P5875
P6179
1038495450